Canterbury DHB

Context

Chronic Rhinosinusitis

Pathogens

Drug Treatment

Organisms with decreased penicillin susceptibility

Consult Infection Diseases/Clinical Microbiology

Empiric

amoxicillin+clavulanic acid

HMLSchedNZFPMLnoids

PO 500 mg/125 mg three times a day

Penicillin allergy

doxycycline

HMLSchedNZFPML

PO 200 mg on day 1 then 100 mg once a day

OR

roxithromycin

HMLSchedNZFPML

PO 300 mg once a day

Pathogens Known

P. aeruginosa

ciprofloxacin

HMLSchedNZFPMLnoids

PO 750 mg twice a day

S. aureus

flucloxacillin

HMLSchedNZFPMLnoids

PO 500 mg four times a day

Information about this Canterbury DHB document (99227):

Document Owner:

Not assigned (see Who's Who)

Last Updated:

March 2018 (Ear, Nose and Throat)

Next Review Due:

March 2021

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document.

Topic Code: 99227